Information Journal Paper
APA:
Copy. (2018). Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints. INFECTION AND DRUG RESISTANCE, 11(-), 783-790. SID. https://sid.ir/paper/745085/en
Vancouver:
Copy. Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints. INFECTION AND DRUG RESISTANCE[Internet]. 2018;11(-):783-790. Available from: https://sid.ir/paper/745085/en
IEEE:
Copy, “Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints,” INFECTION AND DRUG RESISTANCE, vol. 11, no. -, pp. 783–790, 2018, [Online]. Available: https://sid.ir/paper/745085/en